uniQure NV (QURE)
4.57
-0.18
(-3.79%)
USD |
NASDAQ |
Apr 24, 16:00
4.57
0.00 (0.00%)
After-Hours: 20:00
uniQure Revenue (TTM): 15.84M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 15.84M |
September 30, 2023 | 111.90M |
June 30, 2023 | 111.94M |
March 31, 2023 | 110.02M |
December 31, 2022 | 106.48M |
September 30, 2022 | 61.43M |
June 30, 2022 | 61.97M |
March 31, 2022 | 525.34M |
December 31, 2021 | 524.00M |
September 30, 2021 | 500.40M |
June 30, 2021 | 500.20M |
March 31, 2021 | 37.86M |
December 31, 2020 | 37.51M |
September 30, 2020 | 6.053M |
June 30, 2020 | 5.31M |
March 31, 2020 | 6.249M |
December 31, 2019 | 7.281M |
September 30, 2019 | 6.264M |
June 30, 2019 | 8.366M |
March 31, 2019 | 8.942M |
Date | Value |
---|---|
December 31, 2018 | 11.28M |
September 30, 2018 | 12.26M |
June 30, 2018 | 11.37M |
March 31, 2018 | 13.26M |
December 31, 2017 | 13.11M |
September 30, 2017 | 19.65M |
June 30, 2017 | 24.62M |
March 31, 2017 | 24.12M |
December 31, 2016 | 25.10M |
September 30, 2016 | 19.94M |
June 30, 2016 | 16.26M |
March 31, 2016 | 13.62M |
December 31, 2015 | 10.53M |
September 30, 2015 | 8.619M |
June 30, 2015 | 6.344M |
March 31, 2015 | 5.955M |
December 31, 2014 | 6.365M |
September 30, 2014 | 5.597M |
June 30, 2014 | 6.072M |
March 31, 2014 | 5.636M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
5.31M
Minimum
Jun 2020
525.34M
Maximum
Mar 2022
144.44M
Average
61.43M
Median
Sep 2022
Revenue (TTM) Benchmarks
ProQR Therapeutics NV | 7.046M |
Merus NV | 43.95M |
argenx SE | 1.226B |
Pharming Group | 245.32M |
Pharvaris NV | -- |